MDGL — MADRIGAL PHARMACEUTICALS INC

Ownership history in MATHER GROUP, LLC.  ·  5 quarters on record

This page tracks every 13F SEC filing in which MATHER GROUP, LLC. reported a position in MADRIGAL PHARMACEUTICALS INC (MDGL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 73 — 0% 0.00% $33K $458.66
2025 Q1 UNCHANGED 73 — 0% 0.00% $24K $331.23
2024 Q4 UNCHANGED 73 — 0% 0.00% $22K $308.57
2024 Q3 UNCHANGED 73 — 0% 0.00% $15K $212.22
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    MDGL price (monthly, adj. close)

Other funds also holding MDGL

As of 2025 Q4 — sorted by position size

PAULSON & CO. INC. 3Y 7Y 30.48% RTW INVESTMENTS, LP 3Y 7Y 11.63% Tao Capital Management LP 3Y 10.53% Avoro Capital Advisors LLC 3Y 7Y 10.35% BAKER BROS. ADVISORS LP 3Y 7Y 7.3% Tri Locum Partners LP 3Y 6.5% MPM BioImpact LLC 3Y 6.45% Nan Fung Group Holdings Ltd 3Y 6.19% Rock Springs Capital Management LP 3Y 7Y 4.17% Resolute Capital Asset Partners LLC 3Y 3.07%
← Back to MATHER GROUP, LLC. Holdings